Hannah Collins received treatment at the Medical University of South Carolina Health in Charleston. On a rush order, a drug courier drove a medication that once saved the life of a girl infected with brain-eating amoeba from Orlando, Fla., to the South Carolina hospital. The drug, miltefosine, is manufactured by the drug company Profunda. In a statement, the girl’s family thanked Todd MacLaughlan, Profunda’s CEO, for expeditiously shipping the drug to South Carolina.
Sign up for our FREE E-Weekly for more coverage like this sent to your inbox!
Naegleria fowleri, the brain-eating amoeba, lives in warm freshwater and causes primary amebic meningoencephalitis, which is nearly always fatal.
Learn more about Naegleria fowleri here.
More articles on infection control:
Deadly human infection linked to horseback riding
How temporal predictive analytics can improve antibiotic prescription, sepsis care
18 suspected cases in NY mumps outbreak
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
